KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Cash & Equivalents (2021 - 2025)

Historic Cash & Equivalents for QuidelOrtho (QDEL) over the last 5 years, with Q3 2025 value amounting to $98.1 million.

  • QuidelOrtho's Cash & Equivalents fell 3187.5% to $98.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.1 million, marking a year-over-year decrease of 3187.5%. This contributed to the annual value of $98.3 million for FY2024, which is 1774.06% down from last year.
  • QuidelOrtho's Cash & Equivalents amounted to $98.1 million in Q3 2025, which was down 3187.5% from $151.7 million recorded in Q2 2025.
  • Over the past 5 years, QuidelOrtho's Cash & Equivalents peaked at $1.3 billion during Q2 2022, and registered a low of $79.0 million during Q1 2024.
  • Its 5-year average for Cash & Equivalents is $319.3 million, with a median of $165.6 million in 2023.
  • In the last 5 years, QuidelOrtho's Cash & Equivalents plummeted by 7774.02% in 2024 and then soared by 6088.61% in 2025.
  • QuidelOrtho's Cash & Equivalents (Quarter) stood at $578.4 million in 2021, then plummeted by 63.14% to $213.2 million in 2022, then tumbled by 43.95% to $119.5 million in 2023, then fell by 17.74% to $98.3 million in 2024, then dropped by 0.2% to $98.1 million in 2025.
  • Its Cash & Equivalents stands at $98.1 million for Q3 2025, versus $151.7 million for Q2 2025 and $127.1 million for Q1 2025.